Insider Stock Trading History of Hillsberg Sanford


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hillsberg Sanford since year 2005. The trader's CIK number is 1297696. At the time of this reporting, Hillsberg Sanford is the Director of Genesis Biopharma, Inc . (stock ticker symbol GNBP.OB). See this page for all insider trading activities at Genesis Biopharma, Inc .

Note that in the past Hillsberg Sanford also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Hillsberg Sanford since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-08-22 LBIO Genesis Biopharma, Inc Sale 54,000 9.11 491,724
2015-09-04 LBIO Genesis Biopharma, Inc Sale 16,000 6.84 109,440
2015-09-08 LBIO Genesis Biopharma, Inc Sale 16,500 7.13 117,645
2015-08-03 LBIO Genesis Biopharma, Inc Sale 32,500 8.15 264,875
2015-05-06 LBIO Genesis Biopharma, Inc Sale 50,000 10.00 500,000
2014-01-30 GALE Rxi Pharmaceuticals Corp Option Ex 250,000 1.45 361,250
2014-01-30 GALE Rxi Pharmaceuticals Corp Sale 250,000 5.41 1,352,500
2014-01-17 GALE Rxi Pharmaceuticals Corp Sale 200,000 6.92 1,385,000
2014-01-14 GALE Rxi Pharmaceuticals Corp Option Ex 200,000 .85 170,000
2013-12-12 GALE Rxi Pharmaceuticals Corp Option Ex 50,000 .72 36,000
2010-03-26 RXII Rxi Pharmaceuticals Corp Sale 25,000 5.66 141,500
2007-01-04 DSKT Duska Therapeutics, Inc. Sale 12,500 .04 562
2006-10-23 DSKT Duska Therapeutics, Inc. Sale 50,000 .09 4,500
2006-09-06 DSKT Duska Therapeutics, Inc. Sale 16,400 .10 1,722
2006-08-02 DSKT Duska Therapeutics, Inc. Sale 7,000 .11 770
2006-08-03 DSKT Duska Therapeutics, Inc. Sale 7,200 .11 792
2006-07-25 DSKT Duska Therapeutics, Inc. Sale 10,000 .09 900
2006-07-14 DSKT Duska Therapeutics, Inc. Sale 10,000 .16 1,600
2006-07-10 DSKT Duska Therapeutics, Inc. Sale 20,000 .15 3,100
2006-07-11 DSKT Duska Therapeutics, Inc. Sale 30,000 .16 4,800
2006-06-29 DSKT Duska Therapeutics, Inc. Sale 25,000 .21 5,250
2006-06-27 DSKT Duska Therapeutics, Inc. Sale 10,000 .26 2,600
2006-06-09 DSKT Duska Therapeutics, Inc. Sale 30,000 .41 12,150
2006-06-08 DSKT Duska Therapeutics, Inc. Sale 20,000 .41 8,139
2006-06-05 DSKT Duska Therapeutics, Inc. Sale 15,000 .45 6,750
2006-06-06 DSKT Duska Therapeutics, Inc. Sale 10,000 .41 4,100
2006-06-02 DSKT Duska Therapeutics, Inc. Sale 10,000 .47 4,650
2006-06-01 DSKT Duska Therapeutics, Inc. Sale 14,000 .45 6,300
2006-05-30 DSKT Duska Therapeutics, Inc. Sale 3,500 .50 1,750

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hillsberg Sanford (Director of Genesis Biopharma, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.